Cargando…

Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain

INTRODUCTION: In recent years, target therapies to specific molecular alterations in advanced non–small cell lung cancer (NSCLC) have been identified and have shown superior efficacy compared to non-targeted treatments. Anaplastic lymphoma kinase (ALK) is one of the therapeutic targets; nevertheless...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majem, Margarita, Álvarez, Rosa, Ortega, Ana Laura, Ruiz de Alda, Lucía, Gordo, Rocío, García, J Francisco, Ivanova-Markova, Yoana, González-Domínguez, Almudena, San Cristóbal, Raquel Sánchez, Rojo, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AboutScience 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793412/ https://www.ncbi.nlm.nih.gov/pubmed/36628311 http://dx.doi.org/10.33393/grhta.2022.2449

Ejemplares similares

Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib
por: Isla, Dolores, et al.
Publicado: (2020)

Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario
por: Nadal, Ernest, et al.
Publicado: (2021)

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program
por: Bernabé-Caro, Reyes, et al.
Publicado: (2022)

Costs of the management of hemophilia A with inhibitors in Spain
por: Bonanad, Santiago, et al.
Publicado: (2021)

Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing
por: Conde, Esther, et al.
Publicado: (2022)

The social return on investment of a new approach to heart failure in the Spanish National Health System
por: Merino, María, et al.
Publicado: (2020)

First Case of Legionnaire's Disease Caused by Legionella anisa in Spain and the Limitations on the Diagnosis of Legionella non-pneumophila Infections
por: Vaccaro, Lucianna, et al.
Publicado: (2016)

Correction: First Case of Legionnaire's Disease Caused by Legionella anisa in Spain and the Limitations on the Diagnosis of Legionella non-pneumophila Infections
por: Vaccaro, Lucianna, et al.
Publicado: (2016)

Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia)
por: Sánchez-Ares, María, et al.
Publicado: (2016)

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
por: Iwama, Eiji, et al.
Publicado: (2014)

PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study
por: Rubio-Viqueira, Belen, et al.
Publicado: (2021)

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer
por: Barrows, Stephanie M, et al.
Publicado: (2019)

A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study
por: Isla, Dolores, et al.
Publicado: (2022)

Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain
por: Bosch, Xavier, et al.
Publicado: (2018)

Criteria heterogeneity in the diagnosis of acute bronchiolitis in Spain()()
por: Cano-Garcinuño, Alfredo, et al.
Publicado: (2019)

Diagnosis and Treatment of Depression in Spain: Are There Gender Inequalities?
por: Cabezas-Rodríguez, Andrea, et al.
Publicado: (2020)

ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice
por: Hofman, Paul
Publicado: (2017)

Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition
por: Masood, Ashiq, et al.
Publicado: (2021)

ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
por: Incharoen, Pimpin, et al.
Publicado: (2016)

Integrated vs non-integrated treatment outcomes in dual diagnosis disorders: A systematic review
por: Chetty, Ashley, et al.
Publicado: (2023)

Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
por: Villarejo-Galende, Alberto, et al.
Publicado: (2022)

Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-small Cell Lung Cancers
por: Hirai, Noriko, et al.
Publicado: (2020)

The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy
por: Zhang, Ning-Ning, et al.
Publicado: (2014)

Assessment of Alectinib vs Ceritinib in ALK-Positive Non–Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data
por: Wilkinson, Samantha, et al.
Publicado: (2021)

The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study
por: Delgado-Ortega, Laura, et al.
Publicado: (2018)

Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients
por: Sánchez-Herrero, Estela, et al.
Publicado: (2020)

Core Biopsy Diagnosis of ALK Positive Inflammatory Myofibroblastic Tumor of Lung: An Interesting Case
por: Sachdev, Ritesh, et al.
Publicado: (2020)

ALK‐rearrangement in non‐small‐cell lung cancer (NSCLC)
por: Du, Xue, et al.
Publicado: (2018)

A retrospective HEART risk score comparation of acute non-traumatic chest pain patients in an emergency department in Spain
por: San Román Arispe, Iris Nathalie, et al.
Publicado: (2021)

Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells
por: Tanizaki, J, et al.
Publicado: (2012)

Mechanisms of suppression of cell growth by dual inhibition of ALK and MEK in ALK-positive non-small cell lung cancer
por: Shrestha, N., et al.
Publicado: (2019)

Health-related factors of psychological distress during the COVID-19 pandemic among non-health workers in Spain
por: Ruiz-Frutos, Carlos, et al.
Publicado: (2021)

A Change in Work-Family/Life or a Return to Traditional Normative Patterns in Spain? Systematic Review
por: Morero-Mínguez, Almudena, et al.
Publicado: (2022)

Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
por: Gómez-Acebo, Inés, et al.
Publicado: (2018)

LAMP kit for diagnosis of non-falciparum malaria in Plasmodium ovale infected patients
por: Cuadros, Juan, et al.
Publicado: (2017)

Juvenile idiopathic arthritis: cross-sectional study of incidence and prevalence observed in a tertiary center of spain
por: San Ildefonso, Marta Medrano, et al.
Publicado: (2014)

Non-Invasive Skin Cancer Diagnosis Using Hyperspectral Imaging for In-Situ Clinical Support
por: Leon, Raquel, et al.
Publicado: (2020)

Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection
por: Melo, Zesergio, et al.
Publicado: (2018)

Primary vs. Secondary Heart Failure Diagnosis: Differences in Clinical Outcomes, Healthcare Resource Utilization and Cost
por: Bueno, Héctor, et al.
Publicado: (2022)

Data-Driven Fault Diagnosis Techniques: Non-Linear Directional Residual vs. Machine-Learning-Based Methods
por: Cartocci, Nicholas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_namv9vchv36li3kbi31g5evee6